SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Comparing Patient Access to Pharmaceuticals in the UK and US
3 references·0 citing·14 second hop
Comparing Patient Access to Pharmaceuticals in the UK and US (2006)Comparing Patient Access to Pharmaceutica…Evidence Of Evidence-Based Health Policy: The Politics Of Systematic Reviews In Coverage Decisions (2005)Evidence Of Evidence-Based He…Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis (2004)Does NICE have a cost‐effecti…Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries (2001)Using economic evidence in re…The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Problems With the Interpretation of Pharmacoeconomic Analyses (2000)Cost-Effectiveness Analysis and the Consistency of Decision Making (2001)Finding legitimacy for the role of budget impact in drug reimbursement decisions (2009)Cost-Utility Analyses of Diagnostic Laboratory Tests: A Systematic Review (2011)Trying to do more Good than Harm in Policy and Practice: The Role of Rigorous, Transparent, Up-to-Date Evaluations (2003)Why certain systematic reviews reach uncertain conclusions (2003)Guidelines for Systematic Review in Conservation and Environmental Management (2006)Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement (2012)Development and validation of a risk-of-bias tool for assessing in vitro studies conducted in dentistry: The QUIN (2022)
this work references cited by second hop

References

  • 2004Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis710 cited
  • 2005Evidence Of Evidence-Based Health Policy: The Politics Of Systematic Reviews In Coverage Decisions124 cited
  • 2001Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries58 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work